Anthem Biosciences IPO allotment status online check can be done through the websites of BSE and NSE, along with the official ...

Anthem Biosciences IPO allotment status is finalised and investors now shift focus towards the Anthem Biosciences IPO listing ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

Anthem Biosciences IPO oversubscribed, set to list with 20-25% gain, raising ₹1,016 crore from anchor investors.

This strong response from different investor categories highlights the market's confidence in ABL's potential as a publicly ...

Colossal Biosciences, powered by AI and amplified by Hollywood's megaphone, is proving that the story of extinction doesn't ...

Anthem Biosciences IPO Allotment: The IPO of Anthem Biosciences is now heading toward its next big step and that is ‘share ...

The Anthem Biosciences IPO bidding window was open from July 14 to July 16, 2025. The share allotment is expected to be ...

The issue was oversubscribed 63.86 times overall, with the retail investor portion subscribed 5.64 times and the ...

Anthem Biosciences IPO Allotment status, Anthem IPO GMP Price: Anthem Biosciences IPO allotment status set to go live today after oversubscription; check your allotment now!

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Anthem Biosciences' IPO allotment has been finalised, with listing scheduled for Monday, July 21. The latest Grey Market Premium (GMP) indicates strong potential listing gains.